Fredun Pharmaceuticals Holds Meetings with Analysts and Investors
Fredun Pharmaceuticals Limited announced that it hosted a series of meetings with analysts and institutional investors on March 25, 2026. The meetings, conducted via Zoom, involved discussions about the company's business operations, industry outlook, and growth strategy.A total of 38 meetings were held between 12:00 PM and 12:40 PM, with participants from Cognizant Capital, A.J. Capital, Allbridge Capital, Dhyana Capital, Helios Capital, Global Business, Tiger Assets, Fyers Assets, Kanakala Capital, PI Square Investments, 9 Rays EquiReseach, Lorvet Consultancy, Samdareeya Capital Ventures, SmartSync Services, Navrathan &Co., Vijit Growth Fund, Ninedot Ventures, 4A Holdings, BlueOcean Asset Management, Alpha AMC, Greengen Capital Partners, Blue Banyan Advisors, BK Securities, and HNI.
The company stated that discussions were limited to information already available in the public domain and that no Unpublished Price Sensitive Information (UPSI) was shared.
This disclosure adheres to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.